Skip to main content

Peer Review reports

From: Clinical outcomes of advanced non-small cell lung cancer patients harboring distinct subtypes of EGFR mutations and receiving first-line tyrosine kinase inhibitors: brain metastasis and de novo T790M matters

Original Submission
27 Sep 2021 Submitted Original manuscript
26 Oct 2021 Reviewed Reviewer Report
6 Nov 2021 Reviewed Reviewer Report
7 Dec 2021 Author responded Author comments - Zhengfei Zhu
16 Dec 2021 Author responded Author comments - Zhengfei Zhu
Resubmission - Version 2
7 Dec 2021 Submitted Manuscript version 2
24 Dec 2021 Author responded Author comments - Zhengfei Zhu
Resubmission - Version 3
24 Dec 2021 Submitted Manuscript version 3
Publishing
19 Jan 2022 Editorially accepted
21 Feb 2022 Article published 10.1186/s12885-022-09245-5

You can find further information about peer review here.

Back to article page